Mr Mark Sullivan
MD FRCS (Urol)
GMC number: 3338812
Year of qualification: 1989
Areas of expertise:
General Urology, Haematuria, Kidney Surgery, Renal Cancer, Urological Cancer, Robotic Surgery, Andrology, Penile corrective surgery, vasectomy reversal
- Day and time – Nuffield Hospital – The Manor, Oxford
- Royal College of Surgeons of Edinburgh (Fellow)
- British Association of Urological Surgeons
- European Association of Urology
- EAU Robotic Urology Section
Tel: 01865- 307733
Subspecialty services that this consultant provides:
Mr Sullivan is a recognised leading national and international expert in the management of kidney cancer:
Areas of expertise:
Laparoscopic kidney surgery
Robotic kidney surgery
Vasectomy and vasectomy reversal
Mark Sullivan is a Consultant Urological Surgeon and Honorary Senior Lecturer at the Oxford University Hospitals NHS Foundation Trust and University of Oxford respectively. In 2014, he was also appointed Clinical Director of the Renal, Transplant and Urology Directorate at the Oxford University Hospitals NHS Foundation Trust. He qualified from University College London in 1989, and trained in Surgery and Urology at Nottingham, Cambridge. London and Oxford.
Mr Sullivan is an international authority on renal cancer and leading UK surgeon offering open, laparoscopic and robotic options for treatment. Together with David Cranston he provides the renal autotransplantation service in Oxford, a nationally commissioned service, only available in Oxford, which has allowed a cohort of patients in the UK to have complex renal cancers excised from either solitary or both kidneys and thereby avoiding dialysis in most cases. He is also a national authority on erectile dysfunction and is happy to offer specialist advice and management to patients.
Mark’s research activities encompass clinical, translational and basic science programmes on the biology of renal cancer, with specific interests in the molecular mechanisms of disease progression, disease response and novel minimally invasive treatments of small renal cancers (SRM’s). He also has research interests in mechanisms of erectile dysfunction. He has been on the NCRI Renal Cancer Studies group for 7 years and has been involved in a number of national clinical trials involving surgical and chemotherapy treatments for renal cancer.
Consultant Urological Surgeon, Oxford University Hospitals NHS Foundation Trust
Honorary Senior Clinical Lecturer in the Nuffield Department of Surgical Science, University of Oxford